#tigit — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #tigit, aggregated by home.social.
-
IRA lawsuits will be vital test of US’ ability to regulate pharma market —FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia— Roche racks up phase 3 TIGIT win, but trial design leaves doubts --http://bit.ly/w28kSd #Inflationreductionact #drugpricing #fda #crispr #roche #tigit #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
IRA lawsuits will be vital test of US’ ability to regulate pharma market —FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia— Roche racks up phase 3 TIGIT win, but trial design leaves doubts --http://bit.ly/w28kSd #Inflationreductionact #drugpricing #fda #crispr #roche #tigit #clinicaltrials #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
"Integrative analysis of #neuroblastoma by single-cell RNA sequencing identifies the #NECTIN2-#TIGIT axis as a target for #immunotherapy"
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00436-1Great new work from Judith Wienke et al. from the Molenaar lab in the #PrincessMaximaCenter in #Utrecht.
Great to see this out after seeing it in our group meetings several times. In vivo results sometimes are impressive, but very much in a subgroup it seems. Intriguiging, and curious what underlies this.
-
"Integrative analysis of #neuroblastoma by single-cell RNA sequencing identifies the #NECTIN2-#TIGIT axis as a target for #immunotherapy"
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00436-1Great new work from Judith Wienke et al. from the Molenaar lab in the #PrincessMaximaCenter in #Utrecht.
Great to see this out after seeing it in our group meetings several times. In vivo results sometimes are impressive, but very much in a subgroup it seems. Intriguiging, and curious what underlies this.
-
"Integrative analysis of #neuroblastoma by single-cell RNA sequencing identifies the #NECTIN2-#TIGIT axis as a target for #immunotherapy"
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00436-1Great new work from Judith Wienke et al. from the Molenaar lab in the #PrincessMaximaCenter in #Utrecht.
Great to see this out after seeing it in our group meetings several times. In vivo results sometimes are impressive, but very much in a subgroup it seems. Intriguiging, and curious what underlies this.
-
"Integrative analysis of #neuroblastoma by single-cell RNA sequencing identifies the #NECTIN2-#TIGIT axis as a target for #immunotherapy"
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00436-1Great new work from Judith Wienke et al. from the Molenaar lab in the #PrincessMaximaCenter in #Utrecht.
Great to see this out after seeing it in our group meetings several times. In vivo results sometimes are impressive, but very much in a subgroup it seems. Intriguiging, and curious what underlies this.
-
"Integrative analysis of #neuroblastoma by single-cell RNA sequencing identifies the #NECTIN2-#TIGIT axis as a target for #immunotherapy"
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00436-1Great new work from Judith Wienke et al. from the Molenaar lab in the #PrincessMaximaCenter in #Utrecht.
Great to see this out after seeing it in our group meetings several times. In vivo results sometimes are impressive, but very much in a subgroup it seems. Intriguiging, and curious what underlies this.
-
The biopharma patent cliff: 9 drugs losing exclusivity by the end of 2023 -- Roche posts interim TIGIT overall survival data after 'inadvertent disclosure' -- Novartis to lay off another 100-plus employees at US HQ as global restructuring rolls on -- See more on our front page news http://bit.ly/w28kSd #patentcliff #marketexclusivity #roche #tigit #lungcancer #novartis #layoffs #restructuring #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene — More, but slower, medtech approvals -- European regulators probe suicide risk to Ozempic, other Novo drug Saxenda -- See more on our front page news http://bit.ly/w28kSd #novartis #tigit #beigene #medtech #fda #europe #ozempic #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
Novartis retreats from TIGIT, handing $300M candidate back to BeiGene — More, but slower, medtech approvals -- European regulators probe suicide risk to Ozempic, other Novo drug Saxenda -- See more on our front page news http://bit.ly/w28kSd #novartis #tigit #beigene #medtech #fda #europe #ozempic #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma
-
"Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma"
Nice new work based on #scRNAseq from our Drost group colleagues at the #PrincessMaximaCenter. a.o., a potential role of #NECTIN3 and #TIGIT in #tumour-induced T cell dysfunction.
https://www.nature.com/articles/s41467-023-38886-8 -
"Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma"
Nice new work based on #scRNAseq from our Drost group colleagues at the #PrincessMaximaCenter. a.o., a potential role of #NECTIN3 and #TIGIT in #tumour-induced T cell dysfunction.
https://www.nature.com/articles/s41467-023-38886-8 -
"Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma"
Nice new work based on #scRNAseq from our Drost group colleagues at the #PrincessMaximaCenter. a.o., a potential role of #NECTIN3 and #TIGIT in #tumour-induced T cell dysfunction.
https://www.nature.com/articles/s41467-023-38886-8 -
"Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma"
Nice new work based on #scRNAseq from our Drost group colleagues at the #PrincessMaximaCenter. a.o., a potential role of #NECTIN3 and #TIGIT in #tumour-induced T cell dysfunction.
https://www.nature.com/articles/s41467-023-38886-8 -
"Single-cell transcriptomics reveals immune suppression and cell states predictive of patient outcomes in rhabdomyosarcoma"
Nice new work based on #scRNAseq from our Drost group colleagues at the #PrincessMaximaCenter. a.o., a potential role of #NECTIN3 and #TIGIT in #tumour-induced T cell dysfunction.
https://www.nature.com/articles/s41467-023-38886-8
